Dual cell cycle-specific mechanisms mediate the antimitogenic effects of nitric oxide in vascular smooth muscle cells

Journal of Hypertension

Volumn 15, Issue 3, 1997, Pages 275-283

  Sarkar, Rajabrata ^a,b   Gordon, David ^a   Stanley, James C ^a   Webb, R Clinton ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Artery; Growth; Guanylate cyclase; Proliferation; Ribonucleotide reductases; Vasodilators

Indexed keywords

GUANYLATE CYCLASE;

ARTICLE; CELL CYCLE; CELL CYCLE S PHASE; DNA SYNTHESIS; MITOGENESIS; MITOSIS; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE;

EID: 0030936601     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199715030-00009     Document Type: Article

References (51)

1. Kariya K, Kawahara Y, Araki S, Fukuzaki H, Takai Y: Antiproliferative action of cyclic GMP-elevating vasodilators in cultured rabbit aortic smooth muscle cells. Atherosclerosis 1989, 30:143-147.
2. Dubey RK: Vasodilator-derived nitric oxide inhibits fetal calf serum-and angiotensin-II-induced growth of renal arteriolar smooth muscle cells. J Pharmacol Exp Ther 1994, 269:402-408.
3. Garg UC, Hassid A: Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989, 83:1774-1777.
4. Scott-Burden T, Schini VB, Elizondo E, Junquero DC, Vanhoutte PM: Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Effects on cell proliferation. Circ Res 1992, 71:1088-1100
5. McNamara DB, Bedi B, Aurora H, Tena L, Ignarro LJ, Kadowitz PJ, et al.: L-Arginine inhibits balloon catheter-induced intimai hyperplasia. Biochem Biophys Res Commun 1993, 193:291-296.
6. Davies MG, Kim JH, Dalen H, Makhoul RG, Svendsen E, Hagen PO: Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine. Surgery 1994, 116:557-568.
7. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME: Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 1992, 90:1168-1172.
8. Cayatte AJ, Palacino JJ, Horten K, Cohen RA: Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb 1994, 14:753-759.
9. Garg UC, Hassid A: Nitric oxide-generating vasodilators inhibit mitogenesis and proliferation of BALB/C 3T3 fibroblasts by a cyclic GMP-independent mechanism. Biochem Biophys Res Commun 1990, 171:474-479.
10. Cornwall TL, Arnold E, Boerth NJ, Lincoln TM: Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am J Physiol 1994, 267:C1405-C1413.
11. Rossow PW, Riddle VG, Pardee AB: Synthesis of labile, serum-dependent protein in early G1 controls animal cell growth. Proc Natl Acad Sci USA 1979, 76:4446-4450.
12. Morisaki N, Kawano M, Koyama N, Koshikawa T, Umemiya K, Saito Y, et al.: Effects of transforming growth factor-b1 on growth of aortic smooth muscle cells. Atherosclerosis 1991, 88:227-234.
13. Reilly CF, Kindy MS, Brown KE, Rosenberg RD, Sonenshein GE: Heparin prevents vascular smooth muscle cell progression through the G1 phase of the cell cycle. J Biol Chem 1989, 264:6990-6995.
14. 2 in cultured rabbit aortic smooth muscle cells. Atherosclerosis 1988, 71:165-171.
15. Garg UC, Hassid A: Mechanisms of nitrosothiol-induced antimitogenesis in aortic smooth muscle cells. Eur J Pharmacol 1993, 237:243-249.
16. Blair OC, Rod Roti JL: Variation in G1 transit time relative to the cyclohexamide and actinomycin D drug restriction points. Cell Tissue Kinet 1981, 14:91-101.
17. Gordon D, Mohai LG, Schwartz SM: Induction of polyploidy in cultures of neonatal rat aortic smooth muscle cells. Circ Res 1986, 59:633-644.
18. Castellot JJ, Pukac LA, Caleb BL, Wright TC Jr, Karnovsky MJ: Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells. J Cell Biol 1989, 109:3147-3155.
19. Cahill PA, Hassid A: ANF-C-receptor-mediated inhibition of aortic smooth muscle cell proliferation and thymidine kinase activity. Am J Physiol 1994, 266:R194-R203.
20. Loesberg C, van Wijk R, Zandbergen J, van Aken WG, van Mourik JA, de Groot PG: Cell cycle-dependent inhibition of human vascular smooth muscle cell proliferation by prostaglandin E1. Exp Cell Res 1985, 160:117-125.
21. Fukumoto Y, Kawahara Y, Kariya K, Araki S, Fukuzaki H, Takai Y: Independent inhibition of DNA synthesis by protein kinase C, cyclic AMP and interferon alpha/beta in rabbit aortic smooth muscle cells. Biochem Biophys Res Commun 1988, 157:337-345.
22. Gibson A, Babbedge R, Brave SR, Hart SL, Hobbs AJ, Tucker JF, et al: An investigation of some S-nitrosothiols, and of hydroxy-arginine, on the mouse anococcygeus. Br J Pharmacol 1992, 107:715-721.
23. Maragos CM, Morley D, Wink DA, Dunams TM, Saavedra JE, Hoffman A, et al.: Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide. J Med Chem 1991, 34:3242-3247.
24. Charpie JR, Peters A, Webb RC: A photoactivatable source of relaxing factor is increased in genetic hypertension. Hypertension 1994, 23:894-898.
25. 2+ current by isoprenaline, carbechol and phorbol ester in cultured rat aortic vascular smooth muscle (A7r5) cells. Gen Pharmac 1995, 26:369-379.
26. Xiong Z, Sperelakis N, Fenoglio-Preiser C: Regulation of L-type calcium channels by cyclic nucleotides and phosphorylation in smooth muscle cells from rabbit portal vein. J Vasc Res 1994, 31:271-279.
27. i in vascular smooth muscle by inhibition of the calcium current. Cell Calcium 1994, 15:122-131.
28. Akaike T, Yoshida M, Miyamoto Y, Sato K, Kohno M, Sasamoto K, et al: Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/NO through a radical reaction. Biochemistry 1993, 32:827-832.
29. Lepoivre M, Flaman JM, Bobe P, Lemaire G, Henry Y: Quenching of the tyrosyl free radical of ribonucleotide reductase by nitric oxide. Relationship to cytostasis induced in tumor cells by cytotoxic macrophages. J Biol Chem 1994, 269:21891-21897.
30. Kwon NS, Stuehr DJ, Nathan CF: Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide. J Exp Med 1991, 174:761-767.
31. Krokan H, Wist E, Krokan RH: Aphidicolin inhibits DNA synthesis by DNA polymerase alpha and isolated nuclei by a similar mechanism. Nucleic Acids Res 1981, 9:4709-4719.
32. Majesky MW, Schwartz SM, Clowes MM, Clowes AW: Heparin regulates smooth muscle S phase entry in the injured rat carotid artery. Circ Res 1987, 61:296-300.
33. Radomski MW, Rees DD, Dutra A, Moncada S: S-nitroso-glutathione inhibits platelet activation in vitro and in vivo. Br J Pharmacol 1992, 107:745-749.
34. Seki J, Nishio M, Kato Y, Motoyama Y, Yoshida K: FK409, a new nitric oxide donor, suppresses smooth muscle proliferation in the rat model of balloon angioplasty. Atherosclerosis 1996, 117:97-106
35. Tarry WC, Makhoul RG: L-Arginine improves endothelium-dependent vasorelaxation and reduces intimai hyperplasia after balloon angioplasty. Arterioscler Thromb 1994, 14:938-943.
36. Von der Leyen HE, Gibbons GH, Morishita R, Lewis NP, Zwang L, Nakajima M, et al.: Gene therapy inhibiting neointimal hyperplasia: in vivo transfer of endothelial nitric oxide synthase gene. Proc Nat Acad Sci USA 1995, 92:1137-1141.
37. Sarkar R, Meinberg EG, Stanley JC, Gordon D, Webb RC: Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res 1996, 78:225-230.
38. Kolpakov V, Gordon D, Kulik TJ: Nitric-oxide generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circ Res 1995, 76:305-309.
39. Sarkar R, Stanley JC, Webb RC: Localization and mechanism of nitric oxide block in the cell cycle of smooth muscle cells. FASEB J 1995, 9:A315.
40. Stadler J, Curran RD, Ochoa JB, Harbrecht BG, Hoffman RA, Simmons RL, et al.: Effect of endogenous nitric oxide on mitochondrial respiration of rat hepatocytes in vitro and in vivo. Arch Surg 1991, 126:186-191.
41. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 1993, 329:2002-2012.
42. Zhang J, Dawson VL, Dawson TM, Snyder SH: Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 1994, 263:687-689.
43. Pardee AP: G1 events and regulation of cell proliferation. Science 1989, 246:603-608.
44. Kontos HA, Wei EP: Hydroxyl radical-dependent inactivation of guanylate cyclase in cerebral arterioles by methylene blue and by LY83583. Stroke 1993, 24:427-434.
45. Adams RL, Lindsay JG: Hydroxyurea. Reversal of inhibition and use as a cell-synchronizing agent. J Biol Chem 1967, 242:1314-1317.
46. Nakaki T, Nakayama M, Kato R: Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells. Eur J Pharmacol 1990, 189:347-353.
47. Sarkar R, Webb RC, Stanley JC: Nitric oxide inhibition of endothelial cell mitogenesis and proliferation. Surgery 1995, 118:274-279.
48. Marx J: How cells cycle toward cancer. Science 1994, 263:319-321.
49. Medrano EE, Pardee AB: Prevalent deficiency in tumor cells of cycloheximideinduced cycle arrest. Proc Nat Acad Sci USA 1980, 77:4123-4126.
50. Saltis J, Agrotis A, Bobik A: Differential regulation by transforming growth factor-b1 of platelet-derived growth factor-stimulated proliferation of vascular smooth muscle cells from SHR and WKY rats. Clin Exp Pharm Physiol 1992, 19:396-399.
51. Shimizu S, Nara Y, Keiser HR: Differences in response between SHRSP and WKY vascular smooth muscle cells to inhibition of cell proliferation by sodium nitroprusside. Clin Exp Hypertens [A] 1991, 13:787-795.